Fellner, C. (2012). Ipilimumab (Yervoy) Prolongs Survival In Advanced Melanoma: Serious Side Effects and a Hefty Price Tag May Limit Its Use. MediMedia USA, Inc.
Chicago Style CitationFellner, Chris. Ipilimumab (Yervoy) Prolongs Survival In Advanced Melanoma: Serious Side Effects and a Hefty Price Tag May Limit Its Use. MediMedia USA, Inc, 2012.
Cita MLAFellner, Chris. Ipilimumab (Yervoy) Prolongs Survival In Advanced Melanoma: Serious Side Effects and a Hefty Price Tag May Limit Its Use. MediMedia USA, Inc, 2012.
Atenció: Aquestes cites poden no estar 100% correctes.